European Long-acting Antipsychotics in Schizofrenia Trial EULAST
Phase of Trial: Phase IV
Latest Information Update: 11 Sep 2017
At a glance
- Drugs Aripiprazole (Primary) ; Paliperidone (Primary) ; Aripiprazole; Paliperidone
- Indications Schizophrenia
- Focus Therapeutic Use
- Acronyms EULAST
- 04 Sep 2017 Planned End Date changed from 1 Aug 2018 to 1 Jan 2020.
- 04 Sep 2017 Planned primary completion date changed from 1 Feb 2017 to 1 Jul 2018.
- 11 May 2017 This trial has been discontinued in Netherlands as per European Clinical Trial Database record (EudraCT2014-002765-30)